Insider · CIK 0001864280

Macias William L.

Reports to the SEC for 1 company · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001864280

Forms 4 and 5

Insider transactions

48 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-02-19	IMVTImmunovant, Inc.S Sale	Chief Medical Officer	SSale	−2,055 sh	$20.86	−$42.9K	357,353
2025-01-15	IMVTImmunovant, Inc.S Sale	Chief Medical Officer	SSale	−1,883 sh	$23.81	−$44.8K	359,908
2025-01-15	IMVTImmunovant, Inc.S Sale	Chief Medical Officer	SSale	−94 sh	$24.19	−$2,273.86	359,814
2025-01-15	IMVTImmunovant, Inc.S Sale	Chief Medical Officer	SSale	−387 sh	$23.81	−$9,214.47	359,427
2025-01-15	IMVTImmunovant, Inc.S Sale	Chief Medical Officer	SSale	−19 sh	$24.19	−$459.61	359,408
2024-11-20	IMVTImmunovant, Inc.S Sale	Chief Medical Officer	SSale	−3,353 sh	$25.45	−$85.3K	361,791
2024-10-16	IMVTImmunovant, Inc.S Sale	Chief Medical Officer	SSale	−2,627 sh	$28.79	−$75.6K	365,705
2024-10-16	IMVTImmunovant, Inc.S Sale	Chief Medical Officer	SSale	−561 sh	$28.79	−$16.2K	365,144
2024-08-21	IMVTImmunovant, Inc.S Sale	Chief Medical Officer	SSale	−2,907 sh	$31.84	−$92.6K	368,452
2024-08-21	IMVTImmunovant, Inc.S Sale	Chief Medical Officer	SSale	−120 sh	$32.32	−$3,878.4	368,332
2024-07-17	IMVTImmunovant, Inc.S Sale	Chief Medical Officer	SSale	−2,362 sh	$29.64	−$70K	372,041
2024-07-17	IMVTImmunovant, Inc.S Sale	Chief Medical Officer	SSale	−147 sh	$30.55	−$4,490.85	371,894
2024-07-17	IMVTImmunovant, Inc.S Sale	Chief Medical Officer	SSale	−504 sh	$29.64	−$14.9K	371,390
2024-07-17	IMVTImmunovant, Inc.S Sale	Chief Medical Officer	SSale	−31 sh	$30.55	−$947.05	371,359
2024-05-22	IMVTImmunovant, Inc.S Sale	Chief Medical Officer	SSale	−3,247 sh	$29.65	−$96.3K	374,403
2024-04-17	IMVTImmunovant, Inc.S Sale	Chief Medical Officer	SSale	−6,136 sh	$28.80	−$177K	379,794
2024-04-17	IMVTImmunovant, Inc.S Sale	Chief Medical Officer	SSale	−1,796 sh	$29.94	−$53.8K	377,998
2024-04-17	IMVTImmunovant, Inc.S Sale	Chief Medical Officer	SSale	−269 sh	$28.80	−$7,747.2	377,729
2024-04-17	IMVTImmunovant, Inc.S Sale	Chief Medical Officer	SSale	−79 sh	$29.94	−$2,365.26	377,650
2024-04-02	IMVTImmunovant, Inc.A Award	Chief Medical Officer	AAward	+55K sh	—	—	385,930
2024-04-02	IMVTImmunovant, Inc. · Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+68.7K sh	—	—	68,723
2024-02-22	IMVTImmunovant, Inc.S Sale	Chief Medical Officer	SSale	−2,221 sh	$36.15	−$80.3K	330,952
2024-01-18	IMVTImmunovant, Inc.S Sale	Chief Medical Officer	SSale	−424 sh	$41.03	−$17.4K	333,173
2023-11-22	IMVTImmunovant, Inc.S Sale	Chief Medical Officer	SSale	−3,141 sh	$32.75	−$103K	333,721
2023-11-22	IMVTImmunovant, Inc.S Sale	Chief Medical Officer	SSale	−124 sh	$33.52	−$4,156.48	333,597
2023-10-19	IMVTImmunovant, Inc.S Sale	Chief Medical Officer	SSale	−530 sh	$36.80	−$19.5K	336,862
2023-08-24	IMVTImmunovant, Inc.S Sale	Chief Medical Officer	SSale	−12.3K sh	$20.30	−$250K	337,393
2023-08-24	IMVTImmunovant, Inc.S Sale	Chief Medical Officer	SSale	−1 sh	$20.89	−$20.89	337,392
2023-07-19	IMVTImmunovant, Inc.S Sale	Chief Medical Officer	SSale	−426 sh	$24.94	−$10.6K	349,725
2023-04-25	IMVTImmunovant, Inc.S Sale	Chief Medical Officer	SSale	−509 sh	$16.29	−$8,291.61	350,151
2023-04-12	IMVTImmunovant, Inc.A Award	Chief Medical Officer	AAward	+87.7K sh	—	—	350,660
2023-04-12	IMVTImmunovant, Inc. · Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+114K sh	—	—	113,821
2023-02-02	IMVTImmunovant, Inc.S Sale	Chief Medical Officer	SSale	−537 sh	$18.24	−$9,794.88	262,996
2023-01-11	IMVTImmunovant, Inc.S Sale	Chief Medical Officer	SSale	−120 sh	$15.11	−$1,813.2	307,981
2023-01-11	IMVTImmunovant, Inc.S Sale	Chief Medical Officer	SSale	−44.4K sh	$16.75	−$745K	263,533
2022-10-21	IMVTImmunovant, Inc.S Sale	Chief Medical Officer	SSale	−341 sh	$9.67	−$3,297.47	308,101
2022-08-17	IMVTImmunovant, Inc.A Award	Chief Medical Officer	AAward	+113K sh	—	—	308,442
2022-08-17	IMVTImmunovant, Inc. · Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+170K sh	—	—	169,648
2022-07-22	IMVTImmunovant, Inc.S Sale	Chief Medical Officer	SSale	−322 sh	$4.70	−$1,513.4	195,626
2022-04-19	IMVTImmunovant, Inc.S Sale	Chief Medical Officer	SSale	−1,392 sh	$4.98	−$6,932.16	195,948
2022-01-05	IMVTImmunovant, Inc.S Sale	Chief Medical Officer	SSale	−26.8K sh	$8.28	−$222K	197,340
2021-11-05	IMVTImmunovant, Inc.A Award	Chief Medical Officer	AAward	+112K sh	—	—	224,153
2021-11-05	IMVTImmunovant, Inc. · Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+167K sh	—	—	167,325
2021-09-11	IMVTImmunovant, Inc. · Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+369K sh	—	—	369,320
2021-09-11	IMVTImmunovant, Inc. · Stock Option (right to buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−369K sh	—	—	0
2021-06-11	IMVTImmunovant, Inc.A Award	Chief Medical Officer	AAward	+18.7K sh	—	—	18,674
2021-06-11	IMVTImmunovant, Inc.A Award	Chief Medical Officer	AAward	+93.4K sh	—	—	112,045
2021-06-11	IMVTImmunovant, Inc. · Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+369K sh	—	—	369,320

Recent filings

Accepted (ET)
Feb 214
Macias William L.0001764013-25-000032
SEC(opens sec.gov)
Jan 174
Macias William L.0001764013-25-000015
SEC(opens sec.gov)
Nov 224
Macias William L.0001764013-24-000195
SEC(opens sec.gov)
Oct 184
Macias William L.0001764013-24-000173
SEC(opens sec.gov)
Aug 234
Macias William L.0001764013-24-000159
SEC(opens sec.gov)
Jul 194
Macias William L.0001764013-24-000136
SEC(opens sec.gov)
May 244
Macias William L.0001764013-24-000096
SEC(opens sec.gov)
Apr 194
Macias William L.0001764013-24-000081
SEC(opens sec.gov)
Apr 44
Macias William L.0001764013-24-000053
SEC(opens sec.gov)

Companies

Immunovant, Inc.Chief Medical OfficerIMVT

Address

C/O IMMUNOVANT, INC. 320 W 37TH STREET, 6TH FLOOR

NEW YORK, NY, 10018